HYFT MindWalk Holdings, Inc. Total Asset Value of Company

HYFT (MindWalk) - company brandmark

MindWalk Holdings relies on external data centers and third-party contractors to scale its technical support. This price chart of total assets recorded a value of 20.88. MindWalk Holdings attracts promising data scientists through stock option programs. Meanwhile, the market value of this micro-cap already prices in its current modest financials, while the potential for implementing corporate AI modules remains merely a future prospect.

HYFT (MindWalk Holdings) Company Total Assets history from 09/05/2025 to 11/01/2026
Manufactured products of MindWalk Holdings

Total assets represent the aggregate value of all company resources, combining equity and external liabilities. An analysis of total assets (via ROA) with a current value of 20.88 allows for a reverse assessment of the business scale of MindWalk Holdings (HYFT), reflecting the investment efficiency in the development of AI platforms and software robots for the automation of corporate analytics and IT infrastructure.

Key competitors

HLN: Aggregate Business Assets|Aggregate Company Assets Kenvue|Verona Pharma PLC - Total Asset Value of Company|Company Total Assets MENS|LGND (Ligand Corp) - Aggregate Asset Value|Company Total Assets AMRX (Amneal Pharmaceuticals)|Company Total Assets perrigo.com PRGO|ALVO - Aggregate Company Assets|Aggregate Asset Value LQDA (Liquidia Corp)|Galapagos Genomics (GLPG) - Aggregate Company Assets|Cumulative Company Assets ANI Pharmaceuticals Corp|MNKD (MannKind Corporation) - Company Total Assets|Company Total Assets amphastar.com|Cumulative Company Assets PCRX (Pacira BioSciences, Inc.)|SPRY (ARS Pharmaceuticals Inc) - Aggregate Asset Value|Aggregate Company Assets Theravance TBPH|Aquestive Corp (AQST) - Company Assets|SCPH: Cumulative Company Assets|Tectonic Therapeutic, Inc. - Aggregate Business Assets|TNXP: Company Total Assets|China SXT Pharmaceuticals, Inc. - Aggregate Asset Value|EPRX (Eupraxia Pharmaceuticals, Inc.) - Company Total Assets|Company Assets BioHarvest Sciences Inc BHST|Aggregate Company Assets eXoZymes Inc (EXOZ)|ORMP (oramed.com) - Aggregate Asset Value|Aggregate Company Assets Entera Bio ENTX|ABVC - Cumulative Company Assets|Cumberland Pharma - Company Total Assets|Company Total Asset Base Quantum BioPharma Corp QNTM|FibroGen, Inc. (FGEN) - Aggregate Company Assets|Total Business Assets TELO|RANI (Rani Therapeutics Holdings) - Company Total Assets|Total Business Assets SNYR (Synergy CHC Corporation)|Cumulative Company Assets RLYB (Rallybio Corporation)|Cumulative Company Assets lexariabioscience.com LEXX|Company Total Assets PULM (Pulmatrix, Inc.)|Company Total Assets Pheton Holdings Limited PTHL|APM - Aggregate Company Assets|LYRA: Aggregate Company Assets|Impact BioMedical (IBO) - Aggregate Company Assets|TNF Pharmaceuticals, Inc. (TNFA) - Company Total Assets|Cumulative Company Assets YCBD|PRFX: Aggregate Asset Value|Company Total Assets CYTO|LIPO (Lipella Pharmaceuticals Inc) - Aggregate Asset Value|Aggregate Company Assets Optinose OPTN|Pieris Pharma (PIRS) - Company Assets|PROC - Aggregate Company Assets|PTPI: Aggregate Company Assets|QLI: Company Total Assets|Total Business Assets SLRN|TFFP (TFF Pharma) - Company Total Assets